UniProt ID | NIT2_HUMAN | |
---|---|---|
UniProt AC | Q9NQR4 | |
Protein Name | Omega-amidase NIT2 | |
Gene Name | NIT2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 276 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Has a omega-amidase activity. The role of omega-amidase is to remove potentially toxic intermediates by converting alpha-ketoglutaramate and alpha-ketosuccinamate to biologically useful alpha-ketoglutarate and oxaloacetate, respectively. Overexpression decreases the colony-forming capacity of cultured cells by arresting cells in the G2 phase of the cell cycle.. | |
Protein Sequence | MTSFRLALIQLQISSIKSDNVTRACSFIREAATQGAKIVSLPECFNSPYGAKYFPEYAEKIPGESTQKLSEVAKECSIYLIGGSIPEEDAGKLYNTCAVFGPDGTLLAKYRKIHLFDIDVPGKITFQESKTLSPGDSFSTFDTPYCRVGLGICYDMRFAELAQIYAQRGCQLLVYPGAFNLTTGPAHWELLQRSRAVDNQVYVATASPARDDKASYVAWGHSTVVNPWGEVLAKAGTEEAIVYSDIDLKKLAEIRQQIPVFRQKRSDLYAVEMKKP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
26 | Phosphorylation | DNVTRACSFIREAAT CCHHHHHHHHHHHHH | 23.79 | 25159151 | |
37 | Acetylation | EAATQGAKIVSLPEC HHHHCCCEEEECHHH | 50.92 | 26051181 | |
37 | Ubiquitination | EAATQGAKIVSLPEC HHHHCCCEEEECHHH | 50.92 | - | |
47 | Phosphorylation | SLPECFNSPYGAKYF ECHHHHCCCCCHHCC | 10.15 | 28152594 | |
49 | Phosphorylation | PECFNSPYGAKYFPE HHHHCCCCCHHCCHH | 29.54 | 20090780 | |
52 | Ubiquitination | FNSPYGAKYFPEYAE HCCCCCHHCCHHHHH | 42.96 | - | |
52 | Acetylation | FNSPYGAKYFPEYAE HCCCCCHHCCHHHHH | 42.96 | 25953088 | |
60 | Ubiquitination | YFPEYAEKIPGESTQ CCHHHHHHCCCCCHH | 46.13 | - | |
65 | Phosphorylation | AEKIPGESTQKLSEV HHHCCCCCHHHHHHH | 41.89 | 20068231 | |
68 | Acetylation | IPGESTQKLSEVAKE CCCCCHHHHHHHHHH | 54.81 | 25953088 | |
68 | Succinylation | IPGESTQKLSEVAKE CCCCCHHHHHHHHHH | 54.81 | - | |
68 | Succinylation | IPGESTQKLSEVAKE CCCCCHHHHHHHHHH | 54.81 | - | |
68 | Ubiquitination | IPGESTQKLSEVAKE CCCCCHHHHHHHHHH | 54.81 | - | |
92 | Ubiquitination | IPEEDAGKLYNTCAV CCHHHHCHHCEECEE | 49.90 | - | |
96 | Phosphorylation | DAGKLYNTCAVFGPD HHCHHCEECEEECCC | 6.57 | 22210691 | |
109 | Ubiquitination | PDGTLLAKYRKIHLF CCCCEEEEEEEEEEE | 45.62 | - | |
112 | Ubiquitination | TLLAKYRKIHLFDID CEEEEEEEEEEEECC | 31.24 | - | |
123 | Acetylation | FDIDVPGKITFQESK EECCCCCEEEEEECC | 32.29 | 25953088 | |
123 | Succinylation | FDIDVPGKITFQESK EECCCCCEEEEEECC | 32.29 | - | |
123 | Succinylation | FDIDVPGKITFQESK EECCCCCEEEEEECC | 32.29 | - | |
125 | Phosphorylation | IDVPGKITFQESKTL CCCCCEEEEEECCCC | 23.81 | 28857561 | |
129 | Phosphorylation | GKITFQESKTLSPGD CEEEEEECCCCCCCC | 21.84 | 28857561 | |
130 | Ubiquitination | KITFQESKTLSPGDS EEEEEECCCCCCCCC | 53.37 | - | |
130 | Succinylation | KITFQESKTLSPGDS EEEEEECCCCCCCCC | 53.37 | - | |
130 | Succinylation | KITFQESKTLSPGDS EEEEEECCCCCCCCC | 53.37 | - | |
131 | Phosphorylation | ITFQESKTLSPGDSF EEEEECCCCCCCCCC | 41.57 | 28857561 | |
133 | Phosphorylation | FQESKTLSPGDSFST EEECCCCCCCCCCCC | 31.88 | 21815630 | |
137 | Phosphorylation | KTLSPGDSFSTFDTP CCCCCCCCCCCCCCC | 27.32 | 28857561 | |
139 | Phosphorylation | LSPGDSFSTFDTPYC CCCCCCCCCCCCCCH | 31.92 | 28152594 | |
140 | Phosphorylation | SPGDSFSTFDTPYCR CCCCCCCCCCCCCHH | 24.42 | 28152594 | |
143 | Phosphorylation | DSFSTFDTPYCRVGL CCCCCCCCCCHHCCC | 16.38 | 28152594 | |
145 | Phosphorylation | FSTFDTPYCRVGLGI CCCCCCCCHHCCCCE | 8.59 | 20090780 | |
165 | Phosphorylation | FAELAQIYAQRGCQL HHHHHHHHHHCCCEE | 5.65 | 28152594 | |
202 | Phosphorylation | RAVDNQVYVATASPA CCCCCEEEEEECCCC | 3.74 | 27642862 | |
207 | Phosphorylation | QVYVATASPARDDKA EEEEEECCCCCCCCC | 18.10 | - | |
237 | Phosphorylation | EVLAKAGTEEAIVYS HHHHHCCCCEEEEEE | 35.20 | 18452278 | |
244 | Phosphorylation | TEEAIVYSDIDLKKL CCEEEEEECCCHHHH | 19.73 | - | |
249 | Ubiquitination | VYSDIDLKKLAEIRQ EEECCCHHHHHHHHH | 41.83 | - | |
249 | Acetylation | VYSDIDLKKLAEIRQ EEECCCHHHHHHHHH | 41.83 | 25953088 | |
250 | Acetylation | YSDIDLKKLAEIRQQ EECCCHHHHHHHHHH | 61.29 | 2380219 | |
250 | Ubiquitination | YSDIDLKKLAEIRQQ EECCCHHHHHHHHHH | 61.29 | - | |
265 | Dimethylation | IPVFRQKRSDLYAVE CHHHHHCCCCEEEEE | 27.37 | - | |
265 | Methylation | IPVFRQKRSDLYAVE CHHHHHCCCCEEEEE | 27.37 | 24377505 | |
266 | Phosphorylation | PVFRQKRSDLYAVEM HHHHHCCCCEEEEEE | 38.72 | 25159151 | |
269 | Phosphorylation | RQKRSDLYAVEMKKP HHCCCCEEEEEECCC | 17.37 | 19060867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NIT2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NIT2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NIT2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NPTX1_HUMAN | NPTX1 | physical | 22939629 | |
PRDX6_HUMAN | PRDX6 | physical | 22939629 | |
SUCB1_HUMAN | SUCLA2 | physical | 22939629 | |
TIM9_HUMAN | TIMM9 | physical | 22939629 | |
TOIP1_HUMAN | TOR1AIP1 | physical | 22939629 | |
TMEDA_HUMAN | TMED10 | physical | 22939629 | |
OPA1_HUMAN | OPA1 | physical | 22939629 | |
RM12_HUMAN | MRPL12 | physical | 22939629 | |
PPT1_HUMAN | PPT1 | physical | 22939629 | |
RNT2_HUMAN | RNASET2 | physical | 22939629 | |
NPTN_HUMAN | NPTN | physical | 22939629 | |
PGM1_HUMAN | PGM1 | physical | 22939629 | |
TM177_HUMAN | TMEM177 | physical | 22939629 | |
TM189_HUMAN | TMEM189 | physical | 22939629 | |
LDHA_HUMAN | LDHA | physical | 26344197 | |
PARK7_HUMAN | PARK7 | physical | 26344197 | |
PRDX5_HUMAN | PRDX5 | physical | 26344197 | |
PSMG4_HUMAN | PSMG4 | physical | 26344197 | |
TPIS_HUMAN | TPI1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266 AND TYR-269, ANDMASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-145, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-145, AND MASSSPECTROMETRY. |